Exact Mass: 809.3106

MA 144 Y

C42H51NO15 (809.3259)

D000970 - Antineoplastic Agents D007155 - Immunologic Factors

Aclacinomycin B

C42H51NO15 (809.3259)

D000970 - Antineoplastic Agents D007155 - Immunologic Factors

Aclacinomycin Y

C42H51NO15 (809.3259)

D000970 - Antineoplastic Agents D007155 - Immunologic Factors

FCE 24366

C40H47N3O15 (809.3007)

Aclacinomycin B

C42H51NO15 (809.3259)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents D007155 - Immunologic Factors

Kigamicin C

C41H47NO16 (809.2895)

10-Deacetyl-10-oxo-7-epi-taxol

C45H47NO13 (809.3047)

Oligostatin C

C31H55NO23 (809.3165)

C38H51NO18

C38H51NO18 (809.3106)

teuvisside B

C38H51NO18 (809.3106)

Cinerubin R

C42H51NO15 (809.3259)

Rifamexil

C42H55N3O11S (809.3557)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins C254 - Anti-Infective Agent > C258 - Antibiotic

(1R,2R,4S)-2-ethyl-2,7-dihydroxy-1-(methoxycarbonyl)-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxo-5,6-dihydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracen-5-olate

C42H51NO15 (809.3259)

2-[3-[(3S,3S,4R,6S,8R,8aR)-8-[1-azocanyl(oxo)methyl]-6-(4-hydroxyphenyl)-1,2-dioxo-3,4-diphenyl-5-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester

C48H47N3O9 (809.3312)

methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxo-5,6-dihydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

C42H51NO15 (809.3259)

D000970 - Antineoplastic Agents D007155 - Immunologic Factors

aclacinomycin Y zwitterion

C42H51NO15 (809.3259)

A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin Y. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

Aclacinomycin y

C42H51NO15 (809.3259)

An anthracycline antibiotic that is aclacinomycin A in which the ketone function on the trisaccharide fragment has undergone 2,3-dehydrogenation to afford the corresponding enone.

5-[(2r,4r,5s,6as,8s,10r,10as)-8-{[(1r,3s)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl]oxy}-2-[(2s)-2-hydroxypropyl]-4,10-dimethyl-octahydro-2h-pyrano[3,4-d][1,3,6]dioxazocin-5-yl]-1,3-dimethyl-1,3-diazinane-2,4,6-trione

C40H47N3O15 (809.3007)

methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-5-{[(1r,3r,5s,8r,10s,12r,14s)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3259)

methyl 4-{[4-(dimethylamino)-6-methyl-5-({6-methyl-5-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]oxan-2-yl}oxy)oxan-2-yl]oxy}-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3259)

10-deacetyl-10-oxo-7-epitaxol

C45H47NO13 (809.3047)

{"Ingredient_id": "HBIN000081","Ingredient_name": "10-deacetyl-10-oxo-7-epitaxol","Alias": "NA","Ingredient_formula": "C45H47NO13","Ingredient_Smile": "CC1=C2C(=O)C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C","Ingredient_weight": "809.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4764","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "184475","DrugBank_id": "NA"}

4-acetylaminoethylphenyl-1-o-[6-o-(z)-p-meth-oxycinnamoyl-β-d-glucopyranosyl(1→2)]-[β-d-glucopyranosyl(1→3)]-α-l-rhamnopyrano-side

C38H51NO18 (809.3106)

{"Ingredient_id": "HBIN010167","Ingredient_name": "4-acetylaminoethylphenyl-1-o-[6-o-(z)-p-meth-oxycinnamoyl-\u03b2-d-glucopyranosyl(1\u21922)]-[\u03b2-d-glucopyranosyl(1\u21923)]-\u03b1-l-rhamnopyrano-side","Alias": "NA","Ingredient_formula": "C38H51NO18","Ingredient_Smile": "CC1C(C(C(C(O1)OC2=CC=C(C=C2)CCNC(=O)C)OC3C(C(C(C(O3)COC(=O)C=CC4=CC=C(C=C4)OC)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "313","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

n-[2-(4-{[(2s,3r,4r,5s,6s)-5-hydroxy-6-methyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2z)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C38H51NO18 (809.3106)

methyl (1r,2s,4s)-4-{[(2s,4s,5r,6s)-4-(dimethylamino)-5-{[(2r,4s,5r,6r)-4-hydroxy-6-methyl-5-{[(2r,6r)-6-methyl-5-oxo-2,6-dihydropyran-2-yl]oxy}oxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3259)

n-[(1s,2r)-3-{[(1s,2s,3r,4s,7r,9r,10s,15s)-4-(acetyloxy)-2-(benzoyloxy)-1,9-dihydroxy-10,14,17,17-tetramethyl-11,12-dioxo-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-15-yl]oxy}-2-hydroxy-3-oxo-1-phenylpropyl]benzenecarboximidic acid

C45H47NO13 (809.3047)

methyl (1r,2r)-4-{[(2r,4s,5s,6s)-5-{[(5s,12s,14s)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3259)

(1s,19s,20r,21s,22s,23r,24r,26r)-22,23,25-tris(acetyloxy)-21-[(acetyloxy)methyl]-19-hydroxy-3,15,26-trimethyl-6,16-dioxo-2,5,17-trioxa-11-azapentacyclo[16.7.1.0¹,²¹.0³,²⁴.0⁷,¹²]hexacosa-7,9,11-trien-20-yl benzoate

C41H47NO16 (809.2895)

(2z)-n-[2-(4-{[(2s,3r,4r,5s,6s)-5-(acetyloxy)-6-methyl-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}phenyl)ethyl]-3-(4-methoxyphenyl)prop-2-enimidic acid

C38H51NO18 (809.3106)

(2e)-n-[2-(4-{[(2s,3r,4r,5s,6s)-5-(acetyloxy)-6-methyl-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}phenyl)ethyl]-3-(4-methoxyphenyl)prop-2-enimidic acid

C38H51NO18 (809.3106)

2,6,9,30-tetrahydroxy-8-({5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-23-methyl-11,14,16,24-tetraoxa-27-azaoctacyclo[15.14.1.0³,¹².0⁵,¹⁰.0¹³,³².0¹⁹,³¹.0²¹,²⁹.0²³,²⁷]dotriaconta-1(32),2,5(10),12,19(31),20,29-heptaene-4,28-dione

C41H47NO16 (809.2895)

methyl (1r,2r,4s)-4-{[5-({5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl}oxy)-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3259)

n-(2-{4-[(5-hydroxy-6-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[3,4,5-trihydroxy-6-({[3-(4-methoxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]phenyl}ethyl)ethanimidic acid

C38H51NO18 (809.3106)

n-[2-(4-{[(2s,3r,4s,5r,6r)-5-hydroxy-6-methyl-4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-({[(2z)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C38H51NO18 (809.3106)

n-[2-(4-{[(2s,3r,4r,5s,6s)-5-(acetyloxy)-6-methyl-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}phenyl)ethyl]-3-(4-methoxyphenyl)prop-2-enimidic acid

C38H51NO18 (809.3106)

methyl (1r,2r,4s)-4-{[4-(dimethylamino)-6-methyl-5-({6-methyl-5-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]oxan-2-yl}oxy)oxan-2-yl]oxy}-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3259)

22,23,25-tris(acetyloxy)-21-[(acetyloxy)methyl]-19-hydroxy-3,15,26-trimethyl-6,16-dioxo-2,5,17-trioxa-11-azapentacyclo[16.7.1.0¹,²¹.0³,²⁴.0⁷,¹²]hexacosa-7,9,11-trien-20-yl benzoate

C41H47NO16 (809.2895)

methyl (1r,2r)-4-{[(2r,4s,5s,6s)-5-{[(1r,3r,5s,8s,10s,12s,14s)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3259)

(2s,3r,4r,6r)-6-methoxy-2-methyl-3-(methylsulfanyl)oxan-4-ol; (2s,3r,4r,6s)-6-methoxy-2-methyl-3-(methylsulfanyl)oxan-4-ol; n-[2-({[(2s,3r,4s)-3-hydroxy-6-methoxy-2-methyloxan-4-yl]oxy}carbonyl)-4,5-dimethoxyphenyl]-2-methoxyprop-2-enimidic acid

C36H59NO15S2 (809.3326)

n-[(4s)-4-{[(1r,2r)-1-{[(1s)-1-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-4-(n-hydroxyformamido)butyl]-c-hydroxycarbonimidoyl}-2-hydroxyethyl]-c-hydroxycarbonimidoyl}-2-carboxy-2-hydroxyethyl]-c-hydroxycarbonimidoyl}-4-[(hydroxymethylidene)amino]butyl]-1-[2-(2-hydroxyphenyl)-1,3-thiazol-4-yl]methanimine oxide

C33H47N9O13S (809.3014)